Neuphoria Therapeutics Inc. - Common Stock (NEUP) Institutional Ownership $4.88 -0.17 (-3.37%) As of 02/21/2025 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsOwnershipSEC FilingsTrends Institutional Ownership Changes (13F Filings) for Neuphoria Therapeutics Inc. - Common Stock (NASDAQ:NEUP)CurrentInstitutional OwnershipPercentage15.90%Number ofInstitutional Buyers(last 12 months)2Number ofInstitutional Sellers(last 12 months)0 Get NEUP Insider Trade Alerts Want to know when executives and insiders are buying or selling Neuphoria Therapeutics Inc. - Common Stock stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Neuphoria Therapeutics Inc. - Common Stock Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/14/2025 Jane Street Group LLC13,311$46K0.0%N/A0.817% 2/14/2025 Lynx1 Capital Management LP45,806$157K0.1%N/A2.810% (Data available from 1/1/2016 forward) NEUP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NEUP shares? During the previous two years, the following institutional investors and hedge funds held shares of Neuphoria Therapeutics Inc. - Common Stock shares: Lynx1 Capital Management LP ($157K), Jane Street Group LLC ($46K).Learn more on NEUP's institutional investors. What percentage of Neuphoria Therapeutics Inc. - Common Stock stock is owned by institutional investors? 15.90% of Neuphoria Therapeutics Inc. - Common Stock stock is owned by institutional investors. Learn more on NEUP's institutional investor holdings. Which institutional investors have been buying Neuphoria Therapeutics Inc. - Common Stock stock? The following institutional investors have purchased Neuphoria Therapeutics Inc. - Common Stock stock in the last 24 months: Lynx1 Capital Management LP ($45.81K), and Jane Street Group LLC ($13.31K). How much institutional buying is happening at Neuphoria Therapeutics Inc. - Common Stock? Institutional investors have bought a total of 59,117 shares in the last 24 months. This purchase volume represents approximately $0.00 in transactions. Related Companies SNYR Institutional Ownership VRCA Institutional Ownership UBX Institutional Ownership ANEB Institutional Ownership PULM Institutional Ownership PASG Institutional Ownership ANVS Institutional Ownership CALC Institutional Ownership RLYB Institutional Ownership CYTH Institutional Ownership This page (NASDAQ:NEUP) was last updated on 2/22/2025 by MarketBeat.com Staff From Our Partners[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredA strange twist 500 miles from WashingtonEnergy is life. And this year, it could also make national heroes out of President Trump and VP Vance. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neuphoria Therapeutics Inc. - Common Stock Please log in to your account or sign up in order to add this asset to your watchlist. Share Neuphoria Therapeutics Inc. - Common Stock With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
